We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
2015 年1月-2017年9 月广州市第十二人民医院 门诊尘肺病患者用药分析.
- Authors
邓英光; 张紫萍; 郭秀彩
- Abstract
OBJECTIVE: To investigate the application status of drugs in outpatients with pneumonokoniosis in Guangzhou Twelfth People’s Hospital (hereinafter referred to as “ our hospital”),so as to provide reference for the rational drug application. METHODS : Statistical analysis was conducted on drug application data in 6 050 prescriptions of outpatients with pneumonokoniosis in our hospital from Jan. 2015 to Sept. 2017 in terms of general information of patients, consumption amount, consumption sum, defined daily dose system (DDDs) , defined daily cost (DDC) and ratio of consumption sum ranking/DDDs ranking (B/A) , etc. RESULTS: From Jan. 2015 to Sept. 2017, the consumption sum and DDDs of drug application in outpatients with pneumonokoniosis were in an decreasing tendency; immunopotentiator, respiratory system drugs and antipulmonary fibrosis drugs were the main drugs. The consumption sum and DDDs were not consistent. All of the tetrandrine hydrochloride injection, Ganoderma lucidum capsules and ceftizoxime sodium had higher DDC, yet DDC of different categories had few changes; yet the DDC had a slight decrease in 2017, which was relevant to policy of abolishing drugs addition in Guangdong in Jul. 2017. CONCLUSIONS: The drug administration structure in outpatients with pneumonokoniosis in our hospital is basically rational, yet there are still some irrational phenomenon. It is necessary to select proper treatment regimen according to disease progression, complications and economic status of patients.
- Subjects
OUTPATIENT medical care; DUST diseases; TETRANDRINE; PULMONARY fibrosis; DISEASE progression
- Publication
Evaluation & Analysis of Drug-Use in Hospitals of China, 2018, Vol 18, Issue 1, p90
- ISSN
1672-2124
- Publication type
Article
- DOI
10.14009/j.issn.1672-2124.2018.01.027